Norris Cotton Cancer Center combines
advanced cancer research at Dartmouth and the Geisel School of Medicine with patient - centered cancer care provided at Dartmouth - Hitchcock Medical Center, at Dartmouth - Hitchcock regional locations in Manchester, Nashua, and Keene, NH, and St. Johnsbury, VT, and at 12 partner hospitals throughout New Hampshire and Vermont.
How about donating to help others —
advancing cancer research, or feeding the homeless, etc.?
Grateful for support we've received in memory of @Jeopardy champion Cindy Stowell, who donated winnings to help
advance cancer research pic.twitter.com/SJZv0oVw 5t
ASCO's hope, she says, is that Biden «will be able to come up with a comprehensive approach to
advancing cancer research and care.»
The game's design means anyone can help
advance cancer research.
We're sharing our data to
advance cancer research & reimagine medicine for cancer patients.
With the advent of next - generation sequencing, there's no better time to demonstrate the potential of genome science to
advance cancer research.
NEW YORK, August 29, 2016 — The Cancer Research Institute (CRI), a nonprofit organization dedicated to fueling the discovery and development of immunotherapies for all forms of cancer, announced today that it will honor biotechnology company Amgen with the 2016 Oliver R. Grace Award for Distinguished Service in
Advancing Cancer Research at its September gala in New York City.
At the dinner, Parker also received the organization's highest honor for lay individuals, the Oliver R. Grace Award for Distinguished Service in
Advancing Cancer Research, for his outspoken endorsement of cancer immunotherapy and substantial financial support of the Cancer Immunology Translational Research Dream Team that is jointly funded by CRI and Stand Up To Cancer, an organization to which Parker has strong ties.
CRI will continue to forge new partnerships, connect people, and fund clinical trials in order to
advance cancer research.
The Cancer Research Institute announced today that it will honor biotechnology company Genentech and real estate developer and philanthropist Bruce Ratner with the 2017 Oliver R. Grace Award for Distinguished Service in
Advancing Cancer Research.
(TIE) The Pittsburgh Genome Resource Repository of large de-identified national datasets, including The Cancer Genome Atlas (1.1 PB), provides a portal that fosters HPC tool use to
advance cancer research and personalized medicine
Genentech CEO Bill Anderson and Philanthropist Bruce Ratner to Receive the Cancer Research Institute 2017 Oliver R. Grace Award for Distinguished Service in
Advancing Cancer Research
Learn how NCCC's Kerrington Smith, MD (Surgical Oncology) and Peter Kaufman, MD (Hematology Oncology) are
advancing cancer research as the most recent Steven B. Currier Clinical Oncology Scholars.
The focus of this special section is to investigate whether combining principles of art, science and technology with that of cancer biology can
advance cancer research.
Not exact matches
His
research has spanned hematopoiesis, gene therapy, stem cell biology, genomics and
cancer, consistently focusing on bringing the very latest
research advances to patients with heretofore incurable diseases.
PERTH - based Medi - tech
Research Limited may be on the brink of a major
advance in
cancer therapy with its hyaluronic acid technology for the delivery of anti-
cancer drugs.
The corporation was spun out of the Ontario Institute for
Cancer Research (OICR) to develop and
advance late pre-clinical, Phase I or early Phase II potential products.
Prior to joining the OCC, Rossi most recently served as President and CEO of Prostate
Cancer Canada where he helped to advance the research, advocacy, education and awareness of the most common cancer i
Cancer Canada where he helped to
advance the
research, advocacy, education and awareness of the most common
cancer i
cancer in men.
We witness the marvels of technology which have been made possible through the
advances of science, and we wait hopefully for the results of continuing
research, for example in the
cancer field.
Advancing a reason - based scientific world view will
advance the causes of
cancer research and world hunger.
10 % of each sale of this beautiful baby carrier will be benefit the Breast
Cancer Research Foundation, whose mission is to prevent and cure breast cancer by advancing the world's most promising res
Cancer Research Foundation, whose mission is to prevent and cure breast cancer by advancing the world's most promising r
Research Foundation, whose mission is to prevent and cure breast
cancer by advancing the world's most promising res
cancer by
advancing the world's most promising
researchresearch.
Regenerating organs for patient transplants,
research and policy questions for «smart» vehicles,
advances in the fight against
cancer, and voter participation in elections will be discussed in Austin, Texas at the 2018 American Association for the Advancement of Science (AAAS) Annual Meeting, the...
She fostered cross-disciplinary, cross-institutional and cross-national initiatives, among them the Koch Institute for Integrative
Cancer Research, the MIT Energy Initiative and the Massachusetts Green High - Performance Computing Center, and she co-chaired the White House's
Advanced Manufacturing Partnership.
A group of the nation's leading
cancer research scientists and their Cuban counterparts are exploring how to
advance cancer therapy, diagnosis, and prevention, including the use of immunotherapy to harness the body's immune systems to attack and eliminate
cancer cells.
«Several major
advances in recent years have been good news for multiple myeloma patients, but those new drugs only target terminally differentiated
cancer cells and thus can only reduce the bulk of the tumor,» said Jamieson, who is also deputy director of the Sanford Stem Cell Clinical Center, director of the CIRM Alpha Stem Cell Clinic at UC San Diego and director of stem cell research at Moores Cancer Center at UC San Diego H
cancer cells and thus can only reduce the bulk of the tumor,» said Jamieson, who is also deputy director of the Sanford Stem Cell Clinical Center, director of the CIRM Alpha Stem Cell Clinic at UC San Diego and director of stem cell
research at Moores
Cancer Center at UC San Diego H
Cancer Center at UC San Diego Health.
The
research, which appears today as an
advance online publication in the journal Nature, should aid development of more personalized
cancer immunotherapy and
advance diagnosis and treatment of infectious diseases.
However, new
research from the University of Copenhagen reveal that the infections may even benefit the
cancer cells, because the toxins in certain staphylococcus bacteria make healthy cells produce substances that in fact
advance their growth.
If hypofractionated radiation with curative intent can reduce the treatment time for lung
cancer patients by half with no greater toxicity, and with equivalent — if not better — tumor control and survival outcomes, this
research could result in a change in the paradigm of how a large subset of locally
advanced NSCLC patients are treated.»
«Steep funding cuts for the federal health agencies are counterproductive at a time when innovative
research is moving us closer to identifying solutions for rare diseases, new prevention strategies to protect Americans from deadly and costly conditions,
advances in gene therapy, new technologies for understanding the brain, and treatments that harness the ability of our immune system to fight
cancer.»
One bright spot is that the proposal includes funding mandated by the 21st Century Cures Act for the Obama administration's
cancer moonshot, Brain
Research through
Advancing Innovative Neurotechnologies neuroscience initiative, and Precision Medicine Initiative's planned 1 - million - volunteer health study.
A clinical trial conducted by researchers at the Virginia G. Piper
Cancer Center Clinical Trials, a partnership between Scottsdale Healthcare and the Translational Genomics Research Institute (TGen), showed that a new drug called MM - 398, given in combination with 5 - flourouracil (5FU) and leucovorin, produced a significant overall survival rate in patients with advanced, previously - treated pancreatic c
Cancer Center Clinical Trials, a partnership between Scottsdale Healthcare and the Translational Genomics
Research Institute (TGen), showed that a new drug called MM - 398, given in combination with 5 - flourouracil (5FU) and leucovorin, produced a significant overall survival rate in patients with
advanced, previously - treated pancreatic
cancercancer.
The
research was published in the Jan. 18 issue of Molecular Carcinogenesis, which focused on recent
advances in lung
cancer.
«The abstracts we presented at WCLC are prime examples of how our growing body of
research and studies at CTCA at Western are
advancing medicine and hold the potential to provide patients with better
cancer treatments,» Dr. Weiss said.
New products and developments, such as new drugs for
cancer, fresh therapies for rare diseases, progress in medications for HIV / AIDS, and
advances in stem cell
research had the greatest positive impact.
Other UT Southwestern faculty members who contributed to this
research are: Dr. Boning Gao, Assistant Professor with the Hamon Center for Therapeutic Oncology Research and Pharmacology; Dr. Kimmo Hatanpaa, Associate Professor of Pathology; Dr. Kemp Kernstine, Professor of Cardiovascular and Thoracic Surgery and holder of the Robert Tucker Hayes Foundation Distinguished Chair in Cardiothoracic Surgery; Dr. Yang Xie, Associate Professor of Clinical Sciences and Bioinformatics; Dr. Hong Zhu, Assistant Professor of Clinical Sciences and with the Simmons Cancer Center; Dr. Farjana Fattah, Assistant Professor with the Simmons Cancer Center and Pathology; Dr. Masaya Takahashi, Associate Professor with the Advanced Imaging Research and Radiology; Dr. Bipasha Mukherjee, Assistant Professor of Radiation Oncology; Dr. Sandeep Burma, Associate Professor of Radiation Oncology; and Dr. Jonathan Dowell, Professor of Internal M
research are: Dr. Boning Gao, Assistant Professor with the Hamon Center for Therapeutic Oncology
Research and Pharmacology; Dr. Kimmo Hatanpaa, Associate Professor of Pathology; Dr. Kemp Kernstine, Professor of Cardiovascular and Thoracic Surgery and holder of the Robert Tucker Hayes Foundation Distinguished Chair in Cardiothoracic Surgery; Dr. Yang Xie, Associate Professor of Clinical Sciences and Bioinformatics; Dr. Hong Zhu, Assistant Professor of Clinical Sciences and with the Simmons Cancer Center; Dr. Farjana Fattah, Assistant Professor with the Simmons Cancer Center and Pathology; Dr. Masaya Takahashi, Associate Professor with the Advanced Imaging Research and Radiology; Dr. Bipasha Mukherjee, Assistant Professor of Radiation Oncology; Dr. Sandeep Burma, Associate Professor of Radiation Oncology; and Dr. Jonathan Dowell, Professor of Internal M
Research and Pharmacology; Dr. Kimmo Hatanpaa, Associate Professor of Pathology; Dr. Kemp Kernstine, Professor of Cardiovascular and Thoracic Surgery and holder of the Robert Tucker Hayes Foundation Distinguished Chair in Cardiothoracic Surgery; Dr. Yang Xie, Associate Professor of Clinical Sciences and Bioinformatics; Dr. Hong Zhu, Assistant Professor of Clinical Sciences and with the Simmons
Cancer Center; Dr. Farjana Fattah, Assistant Professor with the Simmons
Cancer Center and Pathology; Dr. Masaya Takahashi, Associate Professor with the
Advanced Imaging
Research and Radiology; Dr. Bipasha Mukherjee, Assistant Professor of Radiation Oncology; Dr. Sandeep Burma, Associate Professor of Radiation Oncology; and Dr. Jonathan Dowell, Professor of Internal M
Research and Radiology; Dr. Bipasha Mukherjee, Assistant Professor of Radiation Oncology; Dr. Sandeep Burma, Associate Professor of Radiation Oncology; and Dr. Jonathan Dowell, Professor of Internal Medicine;
In 1953, she founded the
Cancer Research Institute, which still exists today, to honor her father and advance the field of immunotherapy r
Research Institute, which still exists today, to honor her father and
advance the field of immunotherapy
researchresearch.
These include the ability to bring new, innovative products to the market; progress in oncology, such as the approval of Genentech's drug Avastin for breast
cancer and
advances in the use of gene therapy, despite some setbacks; continuing progress in
research on stem cells; the emergence of treatments for previously untreated diseases; and solutions for food and fuel shortages, such as biocrops and biofuels.
«Dr. Aplin's major
research advance is part of a larger effort by the Sidney Kimmel
Cancer Center to develop new strategies for treating melanoma.
«This approach offers a potentially new and safe way of treating liver
cancer, and possibly other
cancers,» said study senior author Dr. Ian Corbin, Assistant Professor in the
Advanced Imaging
Research Center (AIRC) and of Internal Medicine at UT Southwestern.
Extending national breast
cancer screening programs to women over the age of 70 does not result in a decrease in the numbers of
cancers detected at
advanced stages, according to new
research from The Netherlands.
«We sought to better understand and break down the silos and stovepipes that prevent sharing of information and impede
advances in
cancer research and treatment, while building a focused and coordinated effort at home and abroad,» they explain.
The initiatives he oversaw at NCI «will greatly accelerate
cancer research» and «hold potential and promise for great
advances,» von Eschenbach said.
Dr Gerrit - Jan Liefers (MD, PhD), a surgical oncologist and head of the geriatric oncology
research group at Leiden University Medical Centre (Leiden, The Netherlands), said: «For a screening program to be effective, one would expect that the incidence of early stage breast
cancer would increase while the incidence of
advanced stage
cancer would decrease because any
cancer would have been detected at an earlier stage.
The current standard of care for
advanced pancreatic
cancer — a combination of nab - paclitaxel and gemcitabine — was developed by TGen and the HonorHealth
Research Institute, and approved by the U.S. Food and Drug Administration in 2013.
In the April 25 issue of
Cancer Cell, a
research team, led by Xin Lu, PhD, Ludwig director and member at the University of Oxford and a team of scientists from both institutions, describes how p53 is silenced in
advanced melanomas by a protein named iASPP, and applies that information to restore p53 function in such cells.
The initiative is an extension of Biden's 2016 appointment as head of the
Cancer Moonshot Initiative, an assignment President Barack Obama extended, aimed at pulling together federal agencies and private, academic and philanthropic organizations to identify new cancer research topics, break down barriers slowing advances and pinpoint necessary investment areas to advance the fight against c
Cancer Moonshot Initiative, an assignment President Barack Obama extended, aimed at pulling together federal agencies and private, academic and philanthropic organizations to identify new
cancer research topics, break down barriers slowing advances and pinpoint necessary investment areas to advance the fight against c
cancer research topics, break down barriers slowing
advances and pinpoint necessary investment areas to
advance the fight against
cancercancer.
Italian
researches have demonstrated a better way of determining the aggressiveness of tumors in patients with
advanced non-small cell lung
cancer (NSCLC).
Last summer, Biden launched the Biden
Cancer Initiative along with his wife Dr. Jill Biden to continue, outside the federal government, an effort he has led since 2016 to speed advances in cancer research and
Cancer Initiative along with his wife Dr. Jill Biden to continue, outside the federal government, an effort he has led since 2016 to speed
advances in
cancer research and
cancer research and care.
The plenary address titled «Punctuated Equilibrium Meets
Cancer: Big Promise Requires Big Change» will draw from evolutionary biology's punctuated equilibrium theory to set out why stable systems such as cancer research sometimes require swift and fundamental change to ad
Cancer: Big Promise Requires Big Change» will draw from evolutionary biology's punctuated equilibrium theory to set out why stable systems such as
cancer research sometimes require swift and fundamental change to ad
cancer research sometimes require swift and fundamental change to
advance.